Navigation Links
Colby Pharmaceutical Company Announces Dramatic Results: Novel Technology Increases Influenza Vaccine Protection for Elderly Rhesus Monkeys
Date:11/5/2013

/p>

The Journal of Infectious Disease publication reports the most recent results from Colby’s lead cationic lipid-DNA complex (CLDC), JVRS-100. JVRS-100 has now been shown to be an important adjuvant to enhance immune response [humoral (IgG and IgA)] against human influenza vaccine. The results show that Colby’s JVRS-100 adjuvant, when used in combination with an influenza virus vaccine (the Fluzone 2006-2007 seasonal influenza virus vaccine, (including influenza A/New Caledonia/20/99(H1N1) antigen), generates enhanced immunity and superior protection of elderly Rhesus Macques monkeys when challenged with live human flu virus (relative to the Fluzone vaccine alone).

“The Colby data that was just published in the Journal of Infectious Disease clearly shows the remarkable enhancement of immunity from the JVRS-100 added to the human influenza vaccine Fluzone, as measured by the anti-influenza immune responses. There was a dramatic decrease in virus infection in the monkeys inoculated with the JVRS-100 vaccine. Influenza viral replication was completely, or nearly completely, undetectable,” stated David B. Lewis, M.D., an immunologist at Stanford University and Chairman of the Colby Scientific Advisory Board.

In addition, it is remarkable that after a live flu virus challenge, only the JVRS-100 immunized monkeys had significantly lower levels of virus replication (p<0.01) relative to the control animals who were not immunized with JVRS-100. For example, peak levels of the flu virus were 100-fold lower in the respiratory tract secretions of elderly rhesus monkeys inoculated with Fluzone vaccine with the JVRS-100 added, as compared to the Fluzone vaccine alone monkeys.

Colby’s Chief Executive Officer, David Zarling, Ph.D., MBA, remarked that, “This newly published data, from Colby’s recently completed NIH National Institute of Allergy and Infectious Diseases (NIAID)-funded team, is compelling and timely. These well-controlled experime
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
3. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
4. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. The respective roles of the public and private sectors in pharmaceutical innovation
8. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... His Majesty Willem-Alexander, King of the Netherlands to ... Majesty Willem-Alexander, King of the Netherlands, has announced that ... Advanced Biofuels’ Project LIBERTY cellulosic ethanol plant in Emmetsburg, ... take part in the Grand Opening Ceremony to perform ... and tour the plant. POET-DSM is a joint venture ...
(Date:8/21/2014)... BURLINGTON, Mass. , Aug. 21, 2014 /PRNewswire/ ... in Brazil and ... restrictions. The uptake of several newly approved agents, ... for this indication and the launch of emerging ... asthma markets. In particular, the emerging IL-5 inhibitors ...
(Date:8/21/2014)... HONG KONG , Aug. 21, 2014  China Cord ... today announced its plan to release financial results for ... August 28, 2014, after market close in the US.  ... call at 8:00 a.m. ET on Friday, August 29, ... brief overview of the Company,s recent developments, followed by ...
(Date:8/21/2014)... Bulgaria (PRWEB) August 21, 2014 ... released today by Ontotext . Now the ... semantic analysis of structured and unstructured data is available ... the cost of enterprise technology. Organizations that do not ... for data management can use S4 since there is ...
Breaking Biology Technology:His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4
... June 9 Shire Limited (LSE: SHP,Nasdaq: SHPGY), ... recall of two (2) lots of the ADHD ... this action because some DAYTRANA,patches do not meet ... patients and caregivers could have difficulties removing the,liners. ...
... Thirteen Years of Capital Markets ... Experience to AOBO -,- New Role Emphasizes Strategic Growth Plan and Capital Markets Interaction ... ... AOB ) ("AOB" or "the Company"), a pharmaceutical,company dedicated to improving health through the development, ...
... FREMONT, Calif., June 9 WaferGen Biosystems,Inc. (OTC ... expression, genotyping, cell biology and stem cell research ... of assay,development, will provide a poster presentation on ... Institute,s Ninth Annual,Beyond Genome conference. The conference will ...
Cached Biology Technology:Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced 2Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced 3Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced 4American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer 2American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer 3WaferGen to Present at the Ninth Annual Beyond Genome Conference 2
(Date:8/20/2014)... 158 pregnant teenagers in Rochester, NY, nearly half engaged ... ice, cornstarch, vacuum dust, baby powder and soap, and ... Moreover, such teens had significantly lower iron levels as ... , Pregnant teens, regardless of pica, are at higher ... deficiency and anemia. Low iron in pregnant teens raises ...
(Date:8/20/2014)... in this image of the Para and Mato Grosso ... likely intentionally set in order to deforest the land. ... of trees where the land is thereafter converted to ... forestland to farms, ranches, or urban use. The herringbone-patterned ... Amazon Rainforest in the middle of the image are ...
(Date:8/20/2014)... When are athletes who have suffered concussions ready to ... has found that high school athletes who head back ... experience a significant regression in their abilities to simultaneously ... as seen in changes in their balance and/or altered ... Ten of the 12 had returned to activity in ...
Breaking Biology News(10 mins):Pica in pregnant teens linked to low iron 2Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3
... Monitoring oxygen levels in water has applications for ... and a professor at Michigan State University is poised ... oxygen sensors isn,t new. The challenge, however, has been ... carbon dioxide, phosphates and biological wastes. Ruby Ghosh, associate ...
... National Laboratory have an enhanced understanding of a ... remove strontium from water. Insight into this mechanism ... radioactive strontium from existing nuclear waste. Strontium ... the more dangerous radioactive fission materials created within ...
... (Edmonton) A University of Alberta-led research team has determined ... in Alberta, opening up the possibility for an infestation that ... the Atlantic. . A group of U of A tree ... spread eastward from central British Columbia, it successfully jumped species ...
Cached Biology News:Oxygen sensor invention could benefit fisheries to breweries 2Addressing the nuclear waste issue 2Addressing the nuclear waste issue 3
... Effectively condenses and traps a wide variety ... vacuum pump oil. Easy-to-use glass condensation flask (GCF400) ... self contained jar for easy draining. Rapid cooling ... remove glass flask for quick solvent changes ...
... Analysis Note: Protein determined by Biuret ... 25 mM Tris-HCl, pH 7.6, 1 mM ... 2 Preparation Unit Definition: One unit ... per minute at pH 9.8 at 37 ...
Immulon 2 HB 1x8 Strip assembled, C-bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
Immulon 2HB, Flat Bottom, 50/Bx; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
Biology Products: